Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan
PARIS, Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary